The exit strategies of life sciences companies have become more varied due to the current situation being experienced by global capital markets. This is primarily the case for German life sciences companies as well. The choice of exit scenario must be made carefully based on the individual circumstances of the company. The panelists will present and discuss the different exit variations and commercialization strategies, specifically when considering exits of German life sciences companies in other countries (such as the United States or Switzerland)
Collaboration Deals
Joint Ventures
Staged Exits
Milestone Agreements
Indemnification vs. Warranties
Sub-licensing structures
Big pharma deal terms
Speakers:
Sven Riethmueller (Attorney, member of New York and Massachusetts Bars), Foley & Lardner LLP
Dr. Irina Staatz-Granzer, Staatz Business Development and Strategy
Professor Dr. Christof Hettich (Rechtsanwalt), Rittershaus
Related Insights
March 13, 2026
Innovative Technology Insights
Increased Flexibility for Graphical User Interface Design Patent Applicants
On March 12, 2026, the U.S. Patent and Trademark Office ("USPTO") released new guidance that updates prior USPTO practice guidelines for the examination of design patent applications for computer-generated interfaces, commonly known as graphical user interfaces ("GUIs") and icons. In response to the evolution of computer technology, the USPTO highlighted additional design patent subject matter and eliminated historical drawing requirements to increase flexibility for applicants in the GUI space.
March 13, 2026
Health Care Law Today
Iran-Linked Cyberattack: What U.S. Companies Need to Know Now
Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the…
March 13, 2026
Innovative Technology Insights
Iran-Linked Cyberattack: What U.S. Companies Need to Know Now
Overview On March 11, 2026, independent reports confirmed that one of the largest medical device companies in the United States was the…